- Published on:
Havana, Oct 4 (Prensa Latina) The Center for Genetic Engineering and Biotechnology (CIGB) on Sunday highlighted that new Jusvinza drug is Cuba's first therapeutic product based on synthetic peptide, so its production is expected to ramp up.